Leukotriene modifiers in the management of asthma.

M. H. Elnabtity, R. F. Singh, M. A. Ansong, Timothy Craig

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Leukotrienes play a major role in the underlying pathophysiology of asthma. Leukotriene-receptor antagonists and direct leukotriene-synthesis inhibitors may be important new agents in maintenance therapy for asthma. Their role may also extend to attenuating exercise-induced and allergen-induced bronchospasm. This article reviews the effectiveness of available leukotriene modifiers in various clinical studies, reviews their adverse effects profile, and discusses their potential roles in the management of asthma.

Original languageEnglish (US)
Pages (from-to)S1-6
JournalThe Journal of the American Osteopathic Association
Issue number7 Suppl
StatePublished - Jul 1999

All Science Journal Classification (ASJC) codes

  • Complementary and alternative medicine


Dive into the research topics of 'Leukotriene modifiers in the management of asthma.'. Together they form a unique fingerprint.

Cite this